Physician profile
Devon T Isaac
NPI 1124806963
$1,294.13
in general payments reported to CMS, 2019-2025
17 companies · $471 in 2025
The $471 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $87.16 · 2024: $736 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,204 · Education: $89.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,204.18 |
| Education | $89.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $347.89 | 2024-2025 | Farxiga, Breztri, Enhertu |
| Takeda Pharmaceuticals U.S.A., INC. | $147.49 | 2024-2025 | Fruzaqla |
| Rigel Pharmaceuticals, INC. | $133.56 | 2024 | Rezlidhia, Tavalisse |
| Pfizer INC. | $122.05 | 2024 | |
| Daiichi Sankyo INC. | $117.34 | 2024-2025 | Enhertu, Vanflyta |
| Novo Nordisk INC | $59.27 | 2023-2024 | Rybelsus, Ozempic |
| Astellas Pharma US INC | $45.22 | 2023-2024 | Veozah |
| Janssen Biotech, INC. | $44.18 | 2025 | Tecvayli |
| Lilly USA, LLC | $44.14 | 2024 | Mounjaro |
| Exact Sciences Corporation | $42.00 | 2023-2024 | Cologuard Collection Kit |
| Caris Mpi, INC. | $37.25 | 2025 | Mi Cancer Seek |
| Abbvie INC. | $31.04 | 2024 | |
| Gamida Cell INC. | $26.81 | 2025 | Omisirge |
| Syndax Pharmaceuticals, INC. | $24.71 | 2025 | |
| Pharmacyclics LLC, An Abbvie Company | $24.66 | 2023 | Epkinly |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $24.09 | 2025 | Keytruda Qlex, Keytruda |
| Tersera Therapeutics LLC | $22.43 | 2025 | Zoladex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Isaac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.